Patent details

Basic Information

Publication number:

EP3895712

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP211601703

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ENGINEERED NATURAL KILLER CELLS AND USES THEREOF

French Title of Invention:

CELLULES TUEUSES NATURELLES MODIFIÉES ET LEURS UTILISATIONS

German Title of Invention:

MANIPULIERTE NATÜRLICHE KILLERZELLEN UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

11/12/2017

Grant date:

22/06/2022

EP Publication Date:

20/10/2021

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/06/2022

EP B1 Publication Date:

22/06/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/12/2022

Expiration date:

11/12/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/06/2022

 

 

Name:

ONK Therapeutics Limited

Address:

C/O Coll & Company Pier Road Barna Village, Co. Galway H91 V6KV, Ireland (IE)

Inventor

Name:

O'DWYER, Michael Eamon Peter

Address:

Ireland (IE)

Priority

Priority Number:

201662432302 P

Priority Date:

09/12/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 35/15; A61K 39/00; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:

202225

Publication date:

22/06/2022

Description:

Grant (B1)

2

Issue number:

202229

Publication date:

20/07/2022

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages